COVID-19 Vaccine Optimism, Business Leaders' ...

Early Anthropic investor Matt Murphy shares his expectations ahead of the highly anticipated IPO. Then, we speak to the owner of a rare trading card of Dallas Mavericks star Cooper Flagg, which is expected to sell for more than $5 million. Plus, we break down what's behind the ra ...  Show more

Jefferies Chief Market Strategist David Zervos joins to discuss the bond market moves this week. Then, Wellington Management's Matt Witheiler shares where he sees opportunity in the AI space right now. Plus, we discuss what's driving the surge in Manhattan rents this year. Squawk ...  Show more

Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ...  Show more

It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ...

Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ...  Show more

All three averages slipped and Jim Cramer is helping investors navigate market volatility in this holiday-shortened week. First, On opened its newest location in Williamsburg last week and Cramer is sitting down with co-CEO Martin Hoffmann at the Brooklyn flagship to learn mor ...